Biotech & MedTech News
-
Sixth Wave Innovations Inc. Expands Their Valuable IP Portfolio Adding Two ‘MIP’ Patents for the Unique IXOS Metals Extraction and Purification System
January 10, 2023 (Source) – Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (“Sixth Wave”, “SIXW” or…
-
Sixth Wave Issues Shares for Interest
January 06, 2023 (Source) – Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (“Sixth Wave”or the”Company”) is…
-
Voyageur Pharmaceuticals Ltd. Announces First Closing of Private Placement
December 23, 2022 (Source) – Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF) (the “Company” or “Voyageur”) is pleased…
-
Zentek Announces Successful Phase 2 Results of HVAC Testing
December 15, 2022 (Source) – Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company,…
-
Cardiol Therapeutics Commences Multi-Center Phase II Pilot Study of CardiolRx(TM) for the Treatment of Recurrent Pericarditis
The Cleveland Clinic and the Mayo Clinic Study Sites have been Initiated and are Eligible to Recruit Participants…
-
Hemostemix Issued ‘Your Fountain of Youth’ Trademark by Cyprus
December 08, 2022 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is…
-
Voyageur Pharmaceuticals Ltd. Announces Canadian Launch of SmoothX (TM) Barium Contrast Media & Financing
December 08, 2022 (Source) – Voyageur Pharmaceuticals Ltd. (TSXV:VM) (USA:VYYRF) (the “Company” or “Voyageur”) announces that it has initiated its marketing…
-
Zentek’s ZenGUARD(TM) Patent Application Granted by the Canadian Intellectual Property Office
December 07, 2022 (Source) – Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property (IP) development and…
-
Voyageur Pharmaceuticals Ltd. Announces Equity Incentive Compensation
December 02, 2022 (Source) – Voyageur Pharmaceuticals Ltd. (TSXV: VM) (OTC Pink: VYYRF) (the “Company” or “Voyageur”) announces that it…
-
Hemostemix Thanks Neim Malo, Beefstro’s Founder, for His ACP-01 Testimonial Interview
November 30, 2022 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) thanks Mr.…
